KING PHARMACEUTICALS INC·4

Mar 1, 5:09 PM ET

ANDRZEJEWSKI STEPHEN J 4

4 · KING PHARMACEUTICALS INC · Filed Mar 1, 2010

Insider Transaction Report

Form 4
Period: 2010-02-25
ANDRZEJEWSKI STEPHEN J
Chief Commercial Officer
Transactions
  • Award

    Long-Term Performance Unit

    2010-02-25+54,90054,900 total
    Exp: 2011-12-31Common Stock (54,900 underlying)
Footnotes (3)
  • [F1]The Long-Term Performance Units (One Year Performance Cycle) ("Long Term Performance Units") were awarded under the King Pharmaceuticals, Inc. Incentive Plan (the "Incentive Plan"). Each Long-Term Performance Unit represents a contingent right to receive one share of King Pharmaceuticals, Inc. common stock.
  • [F2]The number of Long-Term Performance Units awarded was based on the achievement of certain 2009 annual earnings per share targets established by the Compensation and Human Resources Committee under the Incentive Plan in early 2009.
  • [F3]The Long-Term Performance Units vest in full on December 31, 2011, contingent upon the reporting person's continued employment by King Pharmaceuticals, Inc. as of that date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION